Three Senate Democrats called for an investigation into the developers of brain-computer interface devices, including healthcare and consumer tech products, to make sure the information they collect is properly safeguarded—and not simply sold for profit.
“Unlike other personal data, neural data—captured directly from the human brain—can reveal mental health conditions, emotional states, and cognitive patterns, even when anonymized,” wrote Sens. Chuck Schumer (N.Y.), Maria Cantwell (Wash.) and Ed Markey (Mass.), in a letter (PDF) to the chair of the Federal Trade Commission, Andrew Ferguson. “This information is not only deeply personal; it is also strategically sensitive.”
The senators cited a 2024 review (PDF) conducted by the Neurorights Foundation into the published privacy practices of 30 different companies and their consumer-focused, non-invasive products—ranging from the makers of EEG-equipped headbands that connect with wellness and meditation apps, to the developers of a medically approved therapy for depression.
The report found that…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
The Single-Cell Club Is Rapidly Expanding
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the technology has both laid the foundation for building cell atlases and allowed exploration into how cells within the […]
Humana’s home health brand to expand to Colorado
Humana’s rebranded Kindred at Home division is in the midst of a significant expansion. Click here to view original post
Zynex Reports Third Quarter 2023 Financial Results
Q3 2023 Revenue Increased 20% to $49.9 Million; EPS $0.10 ENGLEWOOD, Colo., Oct. 26, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical […]
